Patent details

Basic Information

Publication number:

EP1144454

PCT Application Number:

PCT/US/1999/025044

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP999710031

PCT Publication Number:

WO/2000/024782

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

MODIFIED PEPTIDES AS THERAPEUTIC AGENTS

French Title of Invention:

PEPTIDES MODIFIES UTILISES COMME AGENTS THERAPEUTIQUES

German Title of Invention:

MODIFIZIERTE PEPTIDE ALS THERAPEUTISCHE MITTEL

SPC Number:

Dates

Filing date:

25/10/1999

Grant date:

12/12/2007

EP Publication Date:

12/12/2007

PCT Publication Date:

04/05/2000

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

17/10/2001

EP B1 Publication Date:

12/12/2007

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

25/10/2014

Expiration date:

25/10/2019

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

25/10/1999

 

 

Name:

AMGEN INC.

Address:

One Amgen Center Drive, Thousand Oaks, CA 91320-1799, United States (US)

Agent

Name:

KIRKPATRICK SA / NV

From:

03/12/2007

Address:

AVENUE WOLFERS 32, 1310, LA HULPE, Belgium (BE)

To:

Inventor

1

Name:

FEIGE Ulrich

Address:

United States (US)

2

Name:

BOONE Thomas, Charles

Address:

United States (US)

3

Name:

LIU Chuan-Fa

Address:

United States (US)

4

Name:

CHEETHAM Janet

Address:

United States (US)

Priority

1

Priority Number:

105371 P

Priority Date:

23/10/1998

Priority Country:

United States (US)

2

Priority Number:

428082

Priority Date:

22/10/1999

Priority Country:

United States (US)

Classification

Main IPC Class:

C07K 19/00;

Filing date	Document type	Number of pages